Vaccination With Flt3L, Radiation, and Poly-ICLC

NCT03789097 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma
Metastatic Breast Cancer
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Pembrolizumab
DRUG: Flt3L
RADIATION: Radiation
DRUG: Poly ICLC

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]